Clinical Vector Process Development (CVPD)
The Clinical Vector Process Development core facility develops and manufactures clinical-grade virus vectors that can be used to genetically engineer therapeutic cells. The facility currently uses HIV-1-derived lentivirus vectors as the primary virus vector, but will expand their service to include other virus vectors in the future.
- Thomas Building, D1-171
- Mailing Address:
- P.O. Box 19024, D1-100 Seattle, WA 98109-1024
- (206) 667-4425
- Hans-Peter Kiem, M.D., Director
Brian Beard, Ph.D., Co-director